LeadIQ logo
Learn more at LeadIQ.com

Insights

NGS Technology Innovation Omixon's pioneering Next Generation Sequencing (NGS) technologies for transplant diagnostics present a compelling sales opportunity for labs seeking state-of-the-art HLA genotyping solutions.

Global Expansion & Acquisition With a recent acquisition by the Werfen group and a global presence serving labs worldwide, Omixon's reach provides sales opportunities to penetrate new markets and leverage existing networks for growth.

Quick Turnaround Solutions The introduction of NanoTYPE HLA™ with rapid turnaround time on the Oxford Nanopore platform offers a competitive edge for labs requiring fast and accurate genotyping, creating sales opportunities in labs focused on efficiency.

Exclusive Partnerships Omixon's partnership with Oxford Nanopore Technologies, allowing for high-resolution HLA typing results within hours, positions the company to offer unique solutions and opens doors for targeted sales strategies in the genomics space.

Key Personnel & Product Development The appointment of industry expert Doug Bost as VP of Transplant Monitoring Products signals a strategic focus on product innovation, presenting sales opportunities to capitalize on cutting-edge transplant monitoring solutions under his leadership.

Similar companies to Omixon

Omixon Tech Stack

Omixon uses 8 technology products and services including Docker, Underscore.js, Lightbox, and more. Explore Omixon's tech stack below.

  • Docker
    Containerization
  • Underscore.js
    Javascript Libraries
  • Lightbox
    Javascript Libraries
  • SiteGround
    Platform As A Service
  • Amazon Web Services
    Platform As A Service
  • Yoast SEO
    Search Engines
  • Google Tag Manager
    Tag Management
  • Bootstrap
    UI Frameworks

Media & News

Omixon's Email Address Formats

Omixon uses at least 1 format(s):
Omixon Email FormatsExamplePercentage
First.Last@omixon.comJohn.Doe@omixon.com
47%
Last@omixon.comDoe@omixon.com
3%
First.Last@omixon.comJohn.Doe@omixon.com
47%
Last@omixon.comDoe@omixon.com
3%

Frequently Asked Questions

Where is Omixon's headquarters located?

Minus sign iconPlus sign icon
Omixon's main headquarters is located at Kaposvár st 14-18. Ground and 1st floor Budapest, 1117 HU. The company has employees across 4 continents, including EuropeNorth AmericaSouth America.

What is Omixon's phone number?

Minus sign iconPlus sign icon
You can contact Omixon's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Omixon's official website and social media links?

Minus sign iconPlus sign icon
Omixon's official website is omixon.com and has social profiles on LinkedIn.

What is Omixon's SIC code NAICS code?

Minus sign iconPlus sign icon
Omixon's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Omixon have currently?

Minus sign iconPlus sign icon
As of April 2024, Omixon has approximately 61 employees across 4 continents, including EuropeNorth AmericaSouth America. Key team members include Chief Technology Officer (cto): E. S.Chief Financial Officer: Z. D.Head Of Software: G. M.. Explore Omixon's employee directory with LeadIQ.

What industry does Omixon belong to?

Minus sign iconPlus sign icon
Omixon operates in the Biotechnology Research industry.

What technology does Omixon use?

Minus sign iconPlus sign icon
Omixon's tech stack includes DockerUnderscore.jsLightboxSiteGroundAmazon Web ServicesYoast SEOGoogle Tag ManagerBootstrap.

What is Omixon's email format?

Minus sign iconPlus sign icon
Omixon's email format typically follows the pattern of . Find more Omixon email formats with LeadIQ.

When was Omixon founded?

Minus sign iconPlus sign icon
Omixon was founded in 2011.
Omixon

Omixon

Biotechnology ResearchBudapest, Hungary51-200 Employees

Omixon is a global transplantation diagnostic company with a mission to provide histocompatibility laboratories with innovative technologies to improve transplant outcomes. Omixon is headquartered in Budapest, Hungary, with operations in the United States, Brazil and the Netherlands serving more than 100 laboratories worldwide.

Building on multidisciplinary competences in bioinformatics, software engineering, molecular biology and regulatory science, Omixon transforms molecular biology innovations into state-of-the-art products in transplant diagnostics.

Omixon was the first to successfully introduce NGS-based HLA typing kit and software in 2014 by bringing Holotype HLA, an NGS-based HLA genotyping product, and HLA Twin software to market. Omixon Twin delivers the most accurate high-resolution HLA genotyping and is used in more than 100+ laboratories worldwide.

Omixon was the first to release a high-resolution HLA genotyping product NanoTYPE HLA™ with less than 5 hours turnaround time on the Oxford Nanopore sequencing platform complemented by NanoTYPER™ analysis software. 

Omixon is the first to bring to market the first donor-derived cell-free DNA kit HoloGRAFT for laboratories with donor-informative genetic markers with primer and probe sequences that are absent in the patient genotype by design.

Section iconCompany Overview

Headquarters
Kaposvár st 14-18. Ground and 1st floor Budapest, 1117 HU
Phone number
Website
omixon.com
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2011
Employees
51-200

Section iconFunding & Financials

Section iconFunding & Financials

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.